Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 17, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 6, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 25, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 16, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 13, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 22, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 9, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 6, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2015View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-79

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information